Loading…
← CockpitCompetitor Analysis › 000503.SZ China Reform Health Management & Services Group Co., Ltd. Class AOpen in the cockpit ↗

China Reform Health Management & Services Group Co., Ltd. Class A000503.SZCompetitor analysis, valuation and peers

China · CNY·Information Technology›Information Technology Services
Momentum neutral 58
Mkt cap
$1.03B
US dollars, full cap
Free float
66%
of shares outstanding
$/day
$43.0M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-17.6 pp
WACC 9.5%
Hurdle
n/a
no reverse DCF
Next earnings
171 days
26 Apr 2027
Close · CNYCN¥7.02
1D-2.8%
1W+7.8%
1M-11.0%
3M-7.0%
6M-11.2%
YTD-20.9%
1Y-28.7%
ATR %6.3%
52w lowhigh44.0% off high

What China Reform Health Management & Services does

Employees: 1,244

China Reform Health Management & Services at a glance

Size China Reform Health Management & Services (000503.SZ) is a China Information Technology company (Information Technology Services) with a market value of $1.03B, the 2244th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥7.02 on 6 Nov 2026.

Performance Over six months the shares fell 11.2%, against +4.4% for the median peer and -16.4% for the China market (cap-weighted) — 10th lowest of 21 in its peer set.

Growth Revenue grew 6.1% over the last twelve months (peer median +2.0%); the operating margin is -45.3% (peer median 1.0%).

Valuation It trades at 20.1× enterprise value to sales against a peer median of 2.3× (3rd most expensive of 21).

Capital Return on invested capital runs 17.6 points below its cost of capital (9.5% WACC).

Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).

Relative performance

809010011011 May 202611 Aug 20266 Nov 2026Peer median 104000503.SZ 89
Six months, rebased to 100: China Reform Health Management & Services against the median of its 20 peers (local-currency closes).

China Reform Health Management & Services financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥346MCN¥349MCN¥354MCN¥329MCN¥309M
Revenue growth—-2%+8%+6%—
Gross profitCN¥102MCN¥69.2MCN¥49.2MCN¥74.7MCN¥47.7M
EBITDAn/a-CN¥111M-CN¥127M-CN¥84.9M-CN¥60.9M
Net income-CN¥408M-CN¥404M-CN¥10.4M-CN¥79.8M-CN¥84.3M
Free cash flow-CN¥112M-CN¥118M-CN¥120M-CN¥154M-CN¥192M
Capital expenditureCN¥40.8MCN¥45.7MCN¥37.6MCN¥52.1MCN¥37.7M
Total debtCN¥348MCN¥410MCN¥278MCN¥219MCN¥93.5M

Quarterly statements and history in the cockpit →

China Reform Health Management & Services competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+50%+100%-20%0%+20%2317GDYN300168E2E002421RPD300226300300446A0023804DXNA9ASE9682TANLA300598603466003040000503.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. China Reform Health Management & Services is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%+60%0×20×40×2317GDYN300168E2E002421300226300300446A4DX600797TANLA603466003040002368000503.SZRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. China Reform Health Management & Services is the large dot.

China Reform Health Management & Services competitors and peer comparison

How China Reform Health Management & Services compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

China Reform Health Management & Services against its 20 peers (data as of 6 Nov 2026)
Measure000503.SZPeer medianRank in peer set
1-month return-11.0%-1.0%4th lowest of 21
6-month return-11.2%+4.4%10th lowest of 21
Distance from 52-week high-44.0%-38.7%9th lowest of 21
Revenue growth (TTM)+6.1%+2.0%10th highest of 21
Operating margin-45.3%1.0%3rd lowest of 21
EV / Sales20.1×2.3×3rd most expensive of 21
ROIC minus cost of capital-17.6 pp-4.6 pp3rd lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
China Reform Health Management & Services 000503.SZChina$1.03B-11%+6%-45%20.1×n/an/a
Systena 2317.TJapan$1.02B+4%+6%16%1.4×-10.9%+9.2%
Grid Dynamics GDYNUnited States$1.05B+88%+7%4%1.8×27.8%+29.9%
Wonders Information 300168.SZChina$1.05B-16%+3%-17%4.4×51.6%-7.6%
E2E Networks E2E.NSIndia$1.06B+49%+252%28%17.9×n/an/a
Shenzhen Das Intellitech 002421.SZChina$996M+5%-17%-17%3.8×14.8%-8.8%
Rapid7 RPDUnited States$989M+113%0%2%1.5×21.4%+15.9%
Shanghai Ganglian E-Commerce 300226.SZChina$979M-21%+1%0%0.1×6.1%+3.9%
Strait Innovation Internet 300300.SZChina$964M-23%-8%-66%42.2×n/an/a
Northsand,Inc 446A.TJapan$1.11B+99%+60%21%4.9×2.3%n/a
Nanjing Sciyon Wisdom Technology 002380.SZChina$957M-22%+7%12%2.5×11.3%+17.4%
4DMedical 4DX.AXAustralia$952M-33%+21%-814%156.7×n/an/a
Nagarro NA9.DEGermany$1.12B+78%+1%8%1.2×3.8%+18.4%
Insigma Technology 600797.SSChina$943M-28%-13%0%2.0×20.0%-2.9%
Asseco South Eastern Europe ASE.WAPoland$940M+20%+7%16%1.9×-0.9%+11.9%
DTS 9682.TJapan$1.14B+14%0%12%1.1×-9.1%+8.4%
Tanla Platforms TANLA.NSIndia$915M+14%+18%14%1.6×15.0%+13.5%
ArcherMind Technology 300598.SZChina$906M-24%+7%-5%2.8×n/an/a
Shanghai Fengyuzhu Culture Technology 603466.SSChina$1.21B+40%-23%-4%5.2×n/an/a
Chutian Dragon 003040.SZChina$869M-15%-23%-7%6.7×n/an/a
Taiji Computer 002368.SZChina$1.24B-23%-37%-27%2.0×4.1%-1.8%

Questions

Which companies are China Reform Health Management & Services's closest peers?
The cockpit's peer set: Systena (2317.T), Grid Dynamics (GDYN), Wonders Information (300168.SZ), E2E Networks (E2E.NS), Shenzhen Das Intellitech (002421.SZ), Rapid7 (RPD), Shanghai Ganglian E-Commerce (300226.SZ), Strait Innovation Internet (300300.SZ).
Is China Reform Health Management & Services expensive compared with its peers?
On ev / sales it trades at 20.1× against a peer median of 2.3×, 3rd most expensive of 21 in its peer set.
How has China Reform Health Management & Services stock performed?
Over six months to 6 Nov 2026 the shares returned -11.2% against +4.4% for the median peer; over one year -28.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.